Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease

Article specifications

This review article was published in 2018 in Journal of Clin Ophthalmol. (IF 2014:2.00) by Spanish ophthalmologists. The aim of this article was to analyze the properties of the combination of hyaluronic acid (HA), carmellose, and osmoprotectors (Optava Fusion®; Allergan, Inc., Irvine, CA, USA) on DED. General considerations on the use of artificial tears are also proposed.

Results

The combination of HA, CMC, and osmoprotectants has proven to be effective in the treatment of the signs and symptoms of dry eye through the synergic action of all its components. Therefore, it can be a recommended option for dry eye of any degree of severity.

Tags: Spain Review article 2018 Clin Ophthalmol